Delivery Order SPE2DB20D2104-SPE2DB23FU94N
- Not listed
- This federal contract award is for the delivery of Mounjaro 5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that is a subsidiary of Cencora, Inc. The contract has a ceiling value of $14,685.54 and an ultimate completion date of May 7, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at up to...
- This federal contract award is for the delivery of Mounjaro 15 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a total ceiling value of $2,072.16. The contract has an ultimate completion date of October 16, 2024 and was awarded on October 15, 2024. This appears to be a delivery order contract, with a firm fixed-price pricing type. The contract is not set aside for any...
- This federal contract award is for the delivery of Mounjaro 12.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $2,777.92 and is a delivery order with a firm fixed price pricing type. It does not have a set-aside designation, indicating it was awarded through full and open competition. The ultimate...
- This federal contract award is for the delivery of Mounjaro 10 mg/0.5 ml pens, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,027.68 and an ultimate completion date of April 29, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is for the delivery of Mounjaro 10 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The prime contractor is AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,401.68 and an ultimate completion date of December 4, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the...
- This federal contract award is for the delivery of Mounjaro 15 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,602.79, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025....
- This federal contract award is for the delivery of Mounjaro 7.5 mg/0.5 ml pens to support federal healthcare programs. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 1, 2024, with a ceiling value of $1,714.88 and an ultimate completion date of April 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
- This federal contract award is for the delivery of Mounjaro 5 mg/0.5 ml pens, a medical product used to treat various health conditions. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,893.00 and an ultimate completion date of September 22, 2023. It is a delivery order contract with a firm fixed-price pricing type. The...
- This federal contract award is for the delivery of Mounjaro 5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $2,253.38 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor supporting the U.S. government. The contract has an ultimate completion date of May 23, 2024 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Mounjaro 7.5 mg/0.5 ml pens, a pharmaceutical product. The award has a ceiling value of $12,131.32 and an ultimate completion date of February 5, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU94NDelivery Order
This federal contract award is for the delivery of Mounjaro 15 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $1,935.00 and an ultimate completion date of August 21, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/18/23 |